Showing results (1651-1660 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|September 15, 2015
A pilot study of JI-101, an inhibitor of VEGFR-2, PDGFR-β, and EphB4 receptors, in combination with everolimus and as a single agent in an ovarian cancer expansion cohortTheresa L Werner, Mark L Wade, Neeraj Agarwal, et al.
Investigational New Drugs|September 25, 2014
A phase I and pharmacokinetic study of ganetespib (STA-9090) in advanced hepatocellular carcinomaLipika Goyal, Raymond C Wadlow, Lawrence S Blaszkowsky, et al.
Investigational New Drugs|September 30, 2014
Acetylamine derivative of diospyrin, a plant-derived binaphthylquinonoid, inhibits human colon cancer growth in Nod-Scid miceSudipta Hazra, Subhalakshmi Ghosh, Amit Kumar, et al.
Investigational New Drugs|January 21, 2015
Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemiaFranck Morschhauser, Louis Terriou, Bertrand Coiffier, et al.
Investigational New Drugs|July 1, 1989
Disposition of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in miceS M el Dareer, K F Tillery, J R Kalin, et al.
Investigational New Drugs|July 1, 1989
Cardiovascular rhythm effects of gamma recombinant DNA interferonG G Friess, T D Brown, R C Wrenn
Investigational New Drugs|November 1, 2013
A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of TumorsRobin L Jones, Stefano Ferrari, Jean Yves Blay, et al.
Investigational New Drugs|January 1, 1985
Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesotheliomaD A Amato, E C Borden, M Shiraki, et al.
Investigational New Drugs|December 18, 2013
Dysphonia induced by anti-angiogenic compoundsErika Saavedra, Antoine Hollebecque, Jean-Charles Soria, et al.
Investigational New Drugs|December 18, 2013
Low skeletal muscle is associated with toxicity in patients included in phase I trialsSophie Cousin, A Hollebecque, S Koscielny, et al.
Pageof 372